Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume $0.01 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Emmaus Life Sciences Short Interest DataEmmaus Life Sciences (EMMA) has a short interest of 13,200 shares, representing 0.03% of the float (the number of shares available for trading by the public). This marks a -60.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 25,257 shares to cover all short positions.Current Short Interest13,200 sharesPrevious Short Interest33,200 sharesChange Vs. Previous Month-60.24%Dollar Volume Sold Short$171.60Short Interest Ratio0.1 Days to CoverLast Record DateJune 30, 2025Outstanding Shares63,870,000 sharesShort Percent of Float0.03%Today's Trading Volume0 sharesAverage Trading Volume25,257 sharesToday's Volume Vs. Average0% Short Selling Emmaus Life Sciences? Sign up to receive the latest short interest report for Emmaus Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEMMA Short Interest Over TimeEMMA Days to Cover Over TimeEMMA Percentage of Float Shorted Over Time Emmaus Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202513,200 shares $171.60 -60.2%0.0%0.1 $0.01 6/15/202533,200 shares $564.40 +4,642.9%0.1%9.2 $0.02 5/31/2025700 shares $13.93 No Change0.0%0 $0.02 5/15/2025700 shares $8.40 -50.0%0.0%0 $0.01 4/30/20251,400 shares $23.10 -75.0%N/A0.4 $0.02 4/15/20255,600 shares $89.60 +16.7%0.0%0.7 $0.02 3/31/20254,800 shares $82.08 -25.0%0.0%0.2 $0.02 3/15/20256,400 shares $175.36 +30.6%0.0%0.1 $0.03 2/28/20254,900 shares $85.75 -51.5%0.0%0 $0.02 2/15/202510,100 shares $451.47 -53.5%0.0%0.1 $0.04 Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202521,700 shares $353.71 +47.6%N/A1.1 $0.02 1/15/202514,700 shares $205.80 +2,000.0%N/A0.6 $0.01 12/31/2024700 shares $5.95 No ChangeN/A0 $0.01 12/15/2024700 shares $4.69 -22.2%N/A0 $0.01 11/30/2024900 shares $26.91 -10.0%N/A0 $0.03 11/15/20241,000 shares $36.50 +42.9%N/A0 $0.04 10/31/2024700 shares $24.50 No ChangeN/A0 $0.04 10/15/2024700 shares $24.50 No ChangeN/A0 $0.04 9/30/2024700 shares $20.86 No ChangeN/A0 $0.03 9/15/2024700 shares $26.25 No ChangeN/A0 $0.04 8/31/2024700 shares $0.21 No ChangeN/A1 $0.00 8/15/2024700 shares $2.10 No ChangeN/A0 $0.00 7/31/2024700 shares $1.75 No ChangeN/A0.1 $0.00 7/15/2024700 shares $49.91 No ChangeN/A0 $0.07 6/30/2024700 shares $70.70 No ChangeN/A0 $0.10 6/15/2024700 shares $64.01 No ChangeN/A0.1 $0.09 5/31/2024700 shares $64.40 No ChangeN/A0.1 $0.09 5/15/2024700 shares $72.10 No ChangeN/A0.3 $0.10 4/30/2024700 shares $70.00 No ChangeN/A0.1 $0.10 4/15/2024700 shares $73.50 -12.5%N/A0.9 $0.11 3/31/2024800 shares $84.00 -89.5%N/A0.1 $0.11 3/15/20247,600 shares $768.36 +33.3%N/A0.4 $0.10 2/29/20245,700 shares $676.02 +714.3%N/A0.1 $0.12 2/15/2024700 shares $67.27 -93.6%N/A0.1 $0.10 1/15/20244,100 shares $369.00 -6.8%N/A0.4 $0.09 12/31/20234,400 shares $440.33 +450.0%N/A0 $0.10 12/15/2023800 shares $88.00 -50.0%N/A0.1 $0.11 11/30/20231,600 shares $208.00 +128.6%N/A0 $0.13 11/15/2023700 shares $77.00 No ChangeN/A0 $0.11 10/31/2023700 shares $84.00 No ChangeN/A0 $0.12This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad)Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.Click here to see the details because this could be the biggest tech story of this decade. 10/15/2023700 shares $105.00 -22.2%N/A0 $0.15 9/30/2023900 shares $112.50 No ChangeN/A0.5 $0.13 9/15/2023900 shares $117.00 +28.6%N/A0.1 $0.13 8/31/2023700 shares $105.88 -41.7%N/A0 $0.15 8/15/20231,200 shares $252.00 No ChangeN/A0.4 $0.21 7/31/20231,200 shares $264.00 +71.4%N/A0.2 $0.22 7/15/2023700 shares $168.35 -50.0%N/A0.1 $0.24 6/30/20231,400 shares $322.00 -68.9%N/A0.2 $0.23 6/15/20234,500 shares $1.22 thousand -65.1%N/A0.8 $0.27 5/31/202312,900 shares $4.13 thousand +1,742.9%N/A0.5 $0.32 5/15/2023700 shares $224.00 -83.7%N/A0 $0.32 4/30/20234,300 shares $1.35 thousand -4.4%N/A0.2 $0.32 4/15/20234,500 shares $1.49 thousand +50.0%N/A0.1 $0.33 3/31/20233,000 shares $907.50 +328.6%N/A0.3 $0.30 3/15/2023700 shares $245.00 No ChangeN/A0.1 $0.35 2/28/2023700 shares $266.00 -91.9%N/A0.1 $0.38 2/15/20238,600 shares $4.04 thousand +244.0%N/A0.2 $0.47 1/31/20232,500 shares $999.50 +257.1%N/A0 $0.40 1/15/2023700 shares $203.00 No ChangeN/A0 $0.29 12/30/2022700 shares $182.21 -87.7%N/A0 $0.26 12/15/20225,700 shares $1.88 thousand +714.3%N/A0.2 $0.33 11/30/2022700 shares $271.60 -86.0%N/A0 $0.39 11/15/20225,000 shares $1.50 thousand +72.4%N/A0.2 $0.30 10/31/20222,900 shares $1.31 thousand +314.3%N/A0 $0.45 10/15/2022700 shares $126.00 No ChangeN/A0 $0.18 9/30/2022700 shares $119.00 -53.3%N/A0 $0.17 9/15/20221,500 shares $450.00 No ChangeN/A0.2 $0.30 8/31/20221,500 shares $540.00 +87.5%N/A0.1 $0.36 8/15/2022800 shares $296.00 +14.3%N/A0 $0.37 7/31/2022700 shares $245.00 No ChangeN/A0 $0.35 7/15/2022700 shares $280.00 No ChangeN/A0.1 $0.40 6/30/2022700 shares $315.00 No ChangeN/A0.1 $0.45 6/15/2022700 shares $252.00 -66.7%N/A0 $0.36 5/31/20222,100 shares $840.00 -83.5%N/A0 $0.40 5/15/202212,700 shares $3.19 thousand +693.8%N/A0.2 $0.25 4/30/20221,600 shares $1.28 thousand -5.9%N/A0.2 $0.80 4/15/20221,700 shares $1.29 thousand +142.9%N/A0 $0.76 3/31/2022700 shares $700.00 -12.5%N/A0 $1.00 3/15/2022800 shares $1.09 thousand No ChangeN/A0.1 $1.36 2/28/2022800 shares $1.16 thousand -33.3%N/A0 $1.45 2/15/20221,200 shares $1.74 thousand +71.4%N/A0 $1.45 1/31/2022700 shares $980.00 -12.5%N/A0 $1.40 1/15/2022800 shares $1.15 thousand +14.3%N/A0 $1.44 12/31/2021700 shares $1.17 thousand No ChangeN/A0 $1.67 12/15/2021700 shares $1.07 thousand -50.0%N/A0 $1.53 11/30/20211,400 shares $3.01 thousand -57.6%N/A0 $2.15 11/15/20213,300 shares $4.03 thousand +230.0%N/A0.1 $1.22 10/29/20211,000 shares $1.43 thousand -23.1%N/A0.1 $1.43 10/15/20211,300 shares $2.11 thousand No ChangeN/A0.1 $1.62 9/30/20211,300 shares $2.08 thousand +44.4%N/A0.1 $1.60This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad)Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.Click here to see the details because this could be the biggest tech story of this decade. 9/15/2021900 shares $1.30 thousand -79.6%N/A0 $1.44 8/31/20214,400 shares $6.82 thousand +46.7%N/A0.3 $1.55 8/13/20213,000 shares $4.65 thousand -37.5%N/A0.3 $1.55 7/30/20214,800 shares $7.20 thousand +433.3%N/A0.4 $1.50 7/15/2021900 shares $1.35 thousand No ChangeN/A0.1 $1.50 6/30/2021900 shares $1.28 thousand -70.0%N/A0.1 $1.42 6/15/20213,000 shares $4.80 thousand +150.0%N/A0.3 $1.60 5/28/20211,200 shares $1.94 thousand +33.3%N/A0.2 $1.62 5/14/2021900 shares $1.31 thousand -74.3%N/A0 $1.45 4/30/20213,500 shares $4.52 thousand +288.9%N/A0.1 $1.29 4/15/2021900 shares $1.22 thousand +28.6%N/A0.1 $1.35 3/31/2021700 shares $1.20 thousand No ChangeN/A0 $1.71 3/15/2021700 shares $1.05 thousand -50.0%N/A0 $1.50 2/26/20211,400 shares $1.97 thousand -33.3%N/A0 $1.41 2/12/20212,100 shares $3.51 thousand -12.5%N/A0 $1.67 1/29/20212,400 shares $2.93 thousand -11.1%N/A0.8 $1.22 1/15/2021700 shares $861.00 -68.2%N/A0 $1.23 12/31/2020700 shares $805.00 No ChangeN/A0 $1.15 12/15/2020700 shares $770.00 -68.2%N/A0 $1.10 11/30/20202,200 shares $2.64 thousand -31.3%N/A0.1 $1.20 11/15/20203,200 shares $2.72 thousand +3.2%N/A0.1 $0.85 10/30/20203,100 shares $2.54 thousand -75.2%N/A0.2 $0.82 10/15/202012,500 shares $9.40 thousand +468.2%N/A0.3 $0.75 9/30/20202,200 shares $2.13 thousand +144.4%N/A0.1 $0.97 9/15/2020900 shares $1.04 thousand -40.0%N/A0 $1.16 EMMA Short Interest - Frequently Asked Questions What is Emmaus Life Sciences' current short interest? Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 13,200 shares of EMMA short. 0.03% of Emmaus Life Sciences' shares are currently sold short. Learn More on Emmaus Life Sciences' current short interest. What is a good short interest percentage for Emmaus Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.03% of Emmaus Life Sciences' floating shares are currently sold short. Is Emmaus Life Sciences' short interest increasing or decreasing? Emmaus Life Sciences saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 13,200 shares, a decrease of 60.2% from the previous total of 33,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Emmaus Life Sciences' short interest compare to its competitors? 0.03% of Emmaus Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Emmaus Life Sciences: Palisade Bio, Inc. (19.94%), ZyVersa Therapeutics, Inc. (9.24%), Adial Pharmaceuticals, Inc. (6.48%), Purple Biotech Ltd. Sponsored ADR (5.09%), Galmed Pharmaceuticals Ltd. (4.17%), Psyence Biomedical Ltd. (2.92%), Spruce Biosciences, Inc. (0.12%), Enveric Biosciences, Inc. (12.57%), PMGC Holdings Inc. (10.58%), Affimed (4.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Emmaus Life Sciences stock? Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emmaus Life Sciences? A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further. How often is Emmaus Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Palisade Bio Short Squeeze ZyVersa Therapeutics Short Squeeze Adial Pharmaceuticals Short Squeeze Purple Biotech Short Squeeze Galmed Pharmaceuticals Short Squeeze Psyence Biomedical Short Squeeze Spruce Biosciences Short Squeeze Enveric Biosciences Short Squeeze PMGC Short Squeeze Affimed Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EMMA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
